Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910)

M. He, M. Gani, O. Livnah, E. A. Stura, D. Beale, J. Coley, I. A. Wilson, M. J. Taussig*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


We describe the specificity profile and V region sequences of a high-affinity monoclonal antibody (mAb), 3910, directed against oestrone-3-glucuronide (E3G). Inhibition studies show that the D-ring is critical for steroid specificity, while the glucuronic acid attached to the A ring is-required for high binding affinity, suggesting that both 'ends' of the E3G ligand are recognized. The V, domain is encoded by a gene from the V(H)7183 family, while V(L) appears to be encoded by the Vk5.1 gene (κII subgroup) with a deletion of six residues from complementarity-determining region-1 (CDR1). The V(H) CDR3 is 10 amino acid residues in length, of which D/N contributes five residues. Comparison of V(H) CDR of 3910 with those of mAb against progesterone (DB3) and digoxin (26-10, 40-50), for which crystal structures have been determined, suggests that aromatic side chains are important for E3G binding and that tyrosine residues H50, H97 and H100 may interact with the ligand. The Fab fragment of 3910 has been crystallized in its native and steroid (E3G and oestriol-3-glucuronide) complexed forms. An X-ray diffraction data set to 3 Å resolution has been collected for the native Fab.

Original languageAmerican English
Pages (from-to)632-639
Number of pages8
Issue number4
StatePublished - 1997
Externally publishedYes


Dive into the research topics of 'Sequence, specificity and crystallization of an oestrone-3-glucuronide antibody (3910)'. Together they form a unique fingerprint.

Cite this